findmyKOL

Ghada Elshimy, MD

Basic profile

Augusta University

ORCIDNPI
RegionAugusta, GA · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ghada Elshimy is an Endocrinology/Metabolic physician affiliated with Augusta University. OpenAlex indexes 62 publications with 279 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
62publications

Distinct works indexed by OpenAlex, matched via ORCID.

279citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1120 15th St # Hb-5025
Augusta, GA 309120004

Telephone

706-721-2131

Provider last certified this registry record 23 Jul 2020.

View the NPPES registry record

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    36.1%
    GLP-1 receptor agonist14.4%
    Trulicity43%Mounjaro37%Ozempic20%
    Part D<11 patients
    Insulin Analog9.4%
    Lantus Solostar54%Humalog28%Tresiba Flextouch U-20018%
    Part D<11 patients

    + 4 more classes in this area

  • Hormonal (systemic)

    35.4%
    l-Thyroxine32.1%
    Levothyroxine Sodium93%Synthroid7%
    Part D<11 patients
    Thyroid Hormone Synthesis Inhibitor1.8%
    Methimazole100%
    Part D<11 patients

    + 1 more class in this area

  • Cardiovascular

    13.7%
    Statin9.2%
    Atorvastatin Calcium52%Rosuvastatin Calcium48%
    Part D18 patients
    Cholesterol absorption inhibitor2.3%
    Ezetimibe100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”